Attillaps Holdings

États‑Unis d’Amérique

 
Quantité totale PI 14
Rang # Quantité totale PI 108 168
Note d'activité PI 1,5/5.0    6
Rang # Activité PI 156 022

Brevets

Marques

5 0
2 0
7 0
0
 
Dernier brevet 2022 - Acetylcholinesterase inhibitors ...
Premier brevet 2014 - Organophosphates for treating af...

Derniers inventions, produits et services

2021 Invention Acetylcholinesterase inhibitors for treatment of dermatological conditions. Embodiments of the i...
2019 Invention Acetylcholinesterase inhibitors for treatment of dermatological conditions. Demodex mites may exi...
Invention Treating dermatological conditions with chloroquine and/or hydroxychloroquine. Embodiments of th...
Invention Treating autoimmune disorders with acetylcholinesterase inhibitors. Provided herein are treatmen...
Invention Treating autoimmune disorders with chloroquine and/or hydroxychloroquine. Provided herein are tr...
Invention Treating autoimmune disorders with ivermectin. DemodexDemodexDemodex mites may exist, this treatm...
Invention Treating autoimmune disorders with acetylcholinesterase inhibitors. Provided herein are treatment...
Invention Treating autoimmune disorders with chloroquine and/or hydroxychloroquine. DemodexDemodexDemodex m...
Invention Treating dermatological conditions with chloroquine and/or hydroxychloroquine. DemodexDemodexDemo...
2018 Invention Treatment of ophthalmological conditions with acetylcholinesterase inhibitors. Embodiments of the...
2015 Invention Acetylcholinesterase inhibitors for treatment of dermatological conditions. Embodiments of the in...
2014 Invention Organophosphates for treating afflictions of the skin. Demodex mites may exist, this treatment ac...
Invention Organophosphates for treating afflictions of the skin. Embodiments of the invention involve treat...